⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
REGN News
Regeneron Pharmaceuticals Inc
Securities Class Action Lawsuit Filed Against Regeneron Pharmaceuticals, Inc. (REGN) – Levi & Korsinsky Represents Shareholders
accessnewswire.com
REGN
Bronstein, Gewirtz & Grossman LLC Urges Regeneron Pharmaceuticals, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
globenewswire.com
REGN
Lost Money on Regeneron Pharmaceuticals, Inc. (REGN)? Contact Levi & Korsinsky Before September 14, 2026 to Join Class Action
accessnewswire.com
REGN
Pomerantz LLP Advises Shareholders of Class Action Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Regeneron ($REGN) Investors Notified of September 14 Court Deadline in Securities Fraud Lawsuit Over Clinical Trials Allegations
accessnewswire.com
REGN
REGN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Pharmaceuticals, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
REGN
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Regeneron Pharmaceuticals, Inc. (REGN) Investors of September 14, 2026 Deadline
accessnewswire.com
REGN
Pomerantz LLP Advises Investors of Class Action Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Regeneron Pharmaceuticals, Inc. – REGN
accessnewswire.com
REGN
$REGN Stock Alert: Regeneron Securities Class Action Filed After 9% Stock Drop Tied to Clinical Trials - September 14 Lead Plaintiff Deadline
accessnewswire.com
REGN